This Biotech Stock 700%: Top Holding After $9.3M Sale
A biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
Discover the crucial years to consider for retirement planning. Equip yourself with strategies for a successful retirement.
21,887 articlesA biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
A top market strategist calls for exiting the Magnificent 7 amid lofty valuations and fading earnings promises, hinti...
Oil jumped sharply in March 2026, but USOI investors faced capped upside and ongoing credit risk. The piece explains ...
GE Vernova sparked intraday excitement as investors reacted to new outlooks on its energy portfolio. This piece break...
Microsoft is staring down a tough start to the year. Is the slide a red flag or a rare chance to buy a tech titan wit...
Advantage (ADV) stunned some on the street with the Q2 2025 numbers, while others saw a path to steady growth. This d...
A clear guide to reading RMTI's Q1 2026 earnings call, what the numbers mean, and how to spot the catalysts that can ...
When a company in niche hardware makes a bold strategic move, the stock can leap. This piece explains how unusual mac...
A chorus of caution from michael burry, paul tudor and a Nobel-winning peer signals a potential reversal in a tech-le...
Costco emerges as a steadier bet than meme-driven plays, backed by membership cash flow and a durable dividend path. ...
A high-level U.S. trip to Havana signals renewed talks on economics and security. The director traveled cuba with a c...
In this stock market today update, Intel pulls back as AI bubble risk concerns rise, even as AI-driven momentum suppo...